Logo
Halalify
Sign In

Is Medicamen Biotech Ltd (MEDICAMEQ) Halal and Shariah Compliant?

MEDICAMEQ
Healthcare
Pharmaceuticals

Current Price

₹272
-4.59%
About Company

Incorporated in 1993, Medicamen Biotech Ltd is a research-led pharmaceutical company involved in developing, manufacturing, and marketing generic finished dosage formulations, and Oncology Fo

Pros
  • Company is expected to give good quarter
Cons
  • The company has delivered a poor sales growth of 10.2% over past five years.
  • Company has a low return on equity of 4.85% over last 3 years.

Analysis Locked

Create a free account to view the complete Halal status, detailed breakdown, purification ratio, and trusted third-party references for Medicamen Biotech Ltd.

Shariah Compliance Analysis of Medicamen Biotech Ltd

When navigating the Indian stock market, ethical investors constantly seek to align their portfolios with Islamic finance principles. A frequent question we receive is whether Medicamen Biotech Ltd (MEDICAMEQ) is Halal and Shariah compliant. To accurately determine the Shariah compliance status of Medicamen Biotech Ltd, we must conduct a comprehensive quantitative and qualitative analysis of both its core business operations and its underlying financial health.

Business Sector Screening for MEDICAMEQ

The very first and most critical step in Halal stock screening is ensuring that the primary business activities of Medicamen Biotech Ltd do not violate Islamic law. Companies heavily involved in prohibited (Haraam) sectors like conventional banking, alcohol, gambling, and adult entertainment are strictly excluded. If Medicamen Biotech Ltd derives its core revenue from permissible (Halal) activities, it successfully advances to the financial ratio analysis phase.

Financial Ratio Analysis

Even if a prominent company like Medicamen Biotech Ltd operates entirely within a Halal sector, it must still pass strict financial screens to guarantee its corporate practices align with Shariah principles.

  • Debt to Total Assets: The interest-bearing debt of Medicamen Biotech Ltd must not exceed the universally accepted threshold (typically 30% or 33%).
  • Illiquid to Total Assets: Medicamen Biotech Ltd must maintain a sufficient percentage of tangible, illiquid assets in its portfolio.
  • Impermissible Income: Any incidental non-compliant revenue (like interest) must strictly remain below 5% of total gross revenue.

Dividend Purification for Medicamen Biotech Ltd

If Medicamen Biotech Ltd (MEDICAMEQ) passes both the sector screens and strict financial tests, it is classified as a Halal stock. However, any incidental impermissible income earned by the company must be cleansed. Investors holding MEDICAMEQ are required to calculate their dividend purification ratio and donate that exact portion to charity, with no expectation of spiritual reward (Sawab), purifying their Halal earnings.

By utilizing our advanced Halal stock screener platform, you can effortlessly track the live Shariah compliance status of Medicamen Biotech Ltd (MEDICAMEQ), view historical compliance trends, and access precise dividend purification calculations. Make informed, ethical investment decisions with confidence.

⚠️ Disclaimer & Research Notice: This analysis is for informational and reference purposes only. It is not financial advice, and we are not responsible for any financial losses or damages incurred. Always do your own research (DYOR) and consult with a qualified Shariah advisor or financial planner before making any investment decisions.